Company intelligence / Profile preview

Seinda Corporation

Guangzhou, Guangdong, China

Ownership: Private
Development stage: Other

Overview

Seinda Corporation is a clinical-stage biotechnology company dedicated to advancing precision medicine in ophthalmology. Founded in 2015 and headquartered in Guangzhou, China, the company integrates innovative diagnostics with targeted therapeutics to address unmet needs in ocular health. Its lead therapeutic candidate, SY-201, is a novel small peptide currently in Phase 3 clinical development for the treatment of Dry Eye Disease, designed to restore ocular surface homeostasis and improve tear film stability. Seinda also leverages its proprietary i-ImmunDx™ platform to provide point-of-care diagnostic solutions that utilize tear-based biomarkers for personalized patient care. The company operates GMP-compliant manufacturing facilities and is supported by a multidisciplinary team of experts and venture capital backing.

Therapeutic areas: Ophthalmology
Modalities: Small peptidePeptidesSmall molecule
Industry: Biotech

Drug pipeline

1 asset

SY-316

Preclinical

Beyond the preview

Go deeper on Seinda Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Seinda Corporation.

Explore the full profile